SOHO State of the Art Updates and Next Questions | Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangements: Diagnostic Pearls and Pitfalls

Bain, 2017, Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2, 71 Telford, 2016, Myeloproliferative neoplasm with eosinophilia and T-lymphoblastic lymphoma with ETV6-LYN gene fusion, Blood Cancer J, 6, 1, 10.1038/bcj.2016.11 Shao, 2020, Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement, Leuk Res, 99, 10.1016/j.leukres.2020.106460 Tang, 2021, Myeloid/lymphoid neoplasms with FLT3 rearrangement, Mod Pathol, 34, 1673, 10.1038/s41379-021-00817-7 Schwaab, 2020, Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes, Am J Hematol, 95, 824, 10.1002/ajh.25825 Pozdnyakova, 2021, Myeloid/Lymphoid neoplasms associated with eosinophilia and rearrangements of PDGFRA, PDGFRB, or FGFR1 or with PCM1-JAK2, Am J Clin Pathol, 155, 160, 10.1093/ajcp/aqaa208 Gerds, 2020, Myeloid/lymphoid neoplasms with eosinophilia and TK fusion genes, version 3.2021, JNCCN J Natl Compr Cancer Netw, 18, 1248, 10.6004/jnccn.2020.0042 Baer, 2018, Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2, Haematologica, 103, e348, 10.3324/haematol.2017.187302 Chmielecki, 2012, Systematic Screen for Tyrosine Kinase Rearrangements Identifies a Novel C6orf204-PDGFRB Fusion in a Patient with Recurrent T-ALL and an Associated Myeloproliferative Neoplasm, Genes Chromosom Cancer, 51, 54, 10.1002/gcc.20930 Ondrejka, 2014, PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: The missing link supporting a stem cell origin, Haematologica, 99, e148, 10.3324/haematol.2014.105452 Kasbekar, 2020, Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia, Blood Adv, 4, 3136, 10.1182/bloodadvances.2020002308 Patterer, 2013, Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1, Ann Hematol, 92, 759, 10.1007/s00277-013-1695-3 Kantarcioglu, 2015, Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature, Int J Hematol, 102, 383, 10.1007/s12185-015-1792-2 He, 2016, BCR-JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia, Cancer Genet, 209, 223, 10.1016/j.cancergen.2016.03.002 Thakral, 2020, Myeloid neoplasm with eosinophilia and BCR-JAK2/t(9;22)(p24;q11.2) morphologically mimicking chronic myeloid leukemia, Ann Diagn Pathol, 44, 151405, 10.1016/j.anndiagpath.2019.151405 Rumi, 2015, Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene, Ann Hematol, 94, 1927, 10.1007/s00277-015-2451-7 Valent, 2012, Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes, J Allergy Clin Immunol, 130, 607, 10.1016/j.jaci.2012.02.019